Skip to main content
. 2022 Sep 28;19:34. doi: 10.1186/s12014-022-09371-z

Table 1.

Subject characteristics in the two participating cohorts. Numbers presented as count (percentage) except where otherwise 570 noted. Hypertension information was not available for the Mount Sinai Biobank cohort.

BQC19 (n = 333) Mount Sinai Biobank (n = 247)
Cases (n = 91) Controls (n = 242) Cases (n = 119) Controls (n = 128)
Age in years (mean) 67.2 66.2 64.8 59.2
Female sex 35 (38.5%) 133 (55.0%) 49 (41.2%) 57 (44.5%)
Hospital site
 Centre Hospitalier de l’Université de Montréal 32 (35.2%) 22 (9.1%)
 Jewish General Hospital 59 (64.8%) 220 (90.1%)
 Mount Sinai Hospital
COVID-19 positive 91 (100%) 202 (83.5%) 119 (100%) 128 (100%)
Diabetes 38 (41.8%) 71 (29.3%) 30 (25.2%) 32 (25.0%)
Chronic obstructive pulmonary disease 16 (17.6%) 27 (11.2%) 14 (11.8%) 8 (6.3%)
Chronic kidney disease 16 (17.6%) 24 (9.9%) 15 (12.6%) 26 (20.3%)
Congestive heart failure 13 (14.3%) 28 (11.6%) 14 (11.8%) 11 (8.6%)
Hypertension 60 (65.9%) 134 (55.4%)
Liver disease 2 (2.2%) 4 (1.7%) 6 (5.0%) 4 (3.1%)
Smoking status
 Current smoker 5 (5.5%) 6 (2.5%) 10 (8.4%) 9 (7.0%)
 Ex-smoker 11 (12.1%) 30 (12.4%) 32 (26.9%) 35 (27.3%)
 Never smoker 39 (42.9%) 172 (71.1%) 47 (39.5%) 65 (50.8)
 Don’t know 36 (39.6%) 34 (14.0%) 30 (25.2%) 19 (14.8%)
HHS Vulnerability Disclosure